Breast Care Leicester Limited 11738683 false 2023-01-01 2023-12-31 2023-12-31 The principal activity of the company is specialist medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true 11738683 2023-01-01 2023-12-31 11738683 2023-12-31 11738683 core:RetainedEarningsAccumulatedLosses 2023-12-31 11738683 core:ShareCapital 2023-12-31 11738683 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 11738683 bus:SmallEntities 2023-01-01 2023-12-31 11738683 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 11738683 bus:FullAccounts 2023-01-01 2023-12-31 11738683 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 11738683 bus:RegisteredOffice 2023-01-01 2023-12-31 11738683 bus:Director1 2023-01-01 2023-12-31 11738683 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 11738683 countries:EnglandWales 2023-01-01 2023-12-31 11738683 2022-01-01 2022-12-31 11738683 2022-12-31 11738683 core:RetainedEarningsAccumulatedLosses 2022-12-31 11738683 core:ShareCapital 2022-12-31 11738683 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 iso4217:GBP xbrli:pure

Registration number: 11738683

Breast Care Leicester Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 December 2023

 

Breast Care Leicester Limited

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

Breast Care Leicester Limited

(Registration number: 11738683)
Abridged Balance Sheet as at 31 December 2023

Note

2023
£

2022
£

Fixed assets

 

Other financial assets

4

96,125

72,223

Current assets

 

Debtors

6,063

1,606

Cash at bank and in hand

 

4,337

6,641

 

10,400

8,247

Creditors: Amounts falling due within one year

(8,673)

(9,182)

Net current assets/(liabilities)

 

1,727

(935)

Total assets less current liabilities

 

97,852

71,288

Provisions for liabilities

(1,493)

-

Net assets

 

96,359

71,288

Capital and reserves

 

Called up share capital

100

100

Profit and loss account

96,259

71,188

Total equity

 

96,359

71,288

For the financial year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 19 August 2024 and signed on its behalf by:
 

Dr S M Pilgrim

Director

 

Breast Care Leicester Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 December 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU
Somerset

These financial statements were authorised for issue by the Board on 19 August 2024.

2

Accounting policies

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Breast Care Leicester Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 December 2023

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2022 - 2).

4

Other financial assets (current and non-current)

Total
£

Non-current financial assets

Cost or valuation

At 1 January 2023

72,223

Fair value adjustments

8,535

Additions

17,251

Disposals

(1,884)

At 31 December 2023

96,125

Carrying amount

At 31 December 2023

96,125

At 31 December 2022

72,223